
ALMITAS CAPITAL LLC
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | ALXO | 2.54M | $4.64M |
![]() | AMLX | 2.12M | $28.85M |
![]() | RLYB | 1.54M | $767.83K |
![]() | DSGN | 1.53M | $11.52M |
![]() | ANTX | 1.43M | $1.81M |
![]() | BRSP | 1.03M | $5.59M |
![]() | GERN | 946K | $1.30M |
![]() | MYPS | 932K | $896.75K |
![]() | LYEL | 578K | $9.38M |
![]() | CNNE | 557K | $10.19M |
![]() | ZNTL | 457K | $690.56K |
![]() | CABA | 387K | $906.73K |
![]() | CCAP | 376K | $5.37M |
![]() | ASA | 335K | $15.36M |
![]() | VTGN | 261K | $927.97K |
![]() | ARR | 217K | $3.24M |
![]() | LEO | 197K | $1.23M |
![]() | ANRO | 195K | $784.48K |
![]() | LADR | 181K | $1.97M |
![]() | OXLC | 120K | $2.03M |

ALX Oncology Holdings Inc.
ALXO
Shares Held
2.54M
Value
$4.64M

Amylyx Pharmaceuticals, Inc.
AMLX
Shares Held
2.12M
Value
$28.85M

Rallybio Corporation
RLYB
Shares Held
1.54M
Value
$767.83K

Design Therapeutics, Inc.
DSGN
Shares Held
1.53M
Value
$11.52M

AN2 Therapeutics, Inc.
ANTX
Shares Held
1.43M
Value
$1.81M

BrightSpire Capital, Inc.
BRSP
Shares Held
1.03M
Value
$5.59M

Geron Corporation
GERN
Shares Held
946K
Value
$1.30M

PLAYSTUDIOS, Inc.
MYPS
Shares Held
932K
Value
$896.75K

Lyell Immunopharma, Inc.
LYEL
Shares Held
578K
Value
$9.38M

Cannae Holdings, Inc.
CNNE
Shares Held
557K
Value
$10.19M

Zentalis Pharmaceuticals, Inc.
ZNTL
Shares Held
457K
Value
$690.56K

Cabaletta Bio, Inc.
CABA
Shares Held
387K
Value
$906.73K

Crescent Capital BDC, Inc.
CCAP
Shares Held
376K
Value
$5.37M

ASA Gold and Precious Metals Limited
ASA
Shares Held
335K
Value
$15.36M

VistaGen Therapeutics, Inc.
VTGN
Shares Held
261K
Value
$927.97K

ARMOUR Residential REIT, Inc.
ARR
Shares Held
217K
Value
$3.24M

BNY Mellon Strategic Municipals, Inc.
LEO
Shares Held
197K
Value
$1.23M

Alto Neuroscience, Inc.
ANRO
Shares Held
195K
Value
$784.48K

Ladder Capital Corp
LADR
Shares Held
181K
Value
$1.97M

Oxford Lane Capital Corp.
OXLC
Shares Held
120K
Value
$2.03M
